Dr David Strain (University of Exeter, Exeter, UK) discusses the effects of liraglutide and semaglutide on stroke subtypes in patients with type 2 diabetes; the results of a post hoc analysis of LEADER, SUSTAIN 6 and PIONEER 6 trials. 

Recorded remotely from Exeter, 2020.

This discussion was supported by an unrestricted educational grant from Novo Nordisk.